货号 | 产品名 | 纯度 | ||
---|---|---|---|---|
A377805 | 现货 |
SMIP004
SMIP004是一种诱导癌细胞选择性凋亡的药物,主要作用于人类前列腺癌细胞,能够下调SKP2并稳定p27。 |
99% | |
A1682351 | 现货 |
Teplizumab/泰普利单抗
Teplizumab是一种人源化IgG1单克隆抗体,通过与CD3结合来调节T细胞活性。Teplizumab具有用于1型糖尿病研究的潜力。 |
99% | |
A1682348 |
Muromonab
|
98% | ||
A1739498 |
Cevostamab/西沃司他单抗
|
95% | ||
A1810800 |
Vibecotamab/维克妥单抗
|
95% | ||
A1810803 |
Ubamatamab/乌巴妥单抗
|
95% | ||
A1810823 |
Vepsitamab/维斯妥单抗
|
95% | ||
A1810726 |
Tidutamab/泰妥单抗
|
95% | ||
A1810845 |
Tepoditamab
|
95% | ||
A1810721 |
Voxalatamab/沃昔莱妥单抗
|
95% | ||
A1961341 |
Solitomab/索利托单抗
|
98% | ||
A1682392 |
Foralumab/福雷芦单抗
|
98% | ||
A451300 |
Lenalidomide HCl/来那度胺盐酸盐
Lenalidomide is a TNF-α secretion inhibitor with IC50 of 13 nM. |
98+% | ||
A1729060 |
Talquetamab/塔奎妥单抗
|
95% | ||
A1703032 |
Otelixizumab/奥昔组单抗
|
95% | ||
A1739499 |
Visilizumab/维西珠单抗
|
95% | ||
A2794095 |
Teplizumab/泰普利单抗
|
99% |